[Primary hyperaldosteronism due to adrenocortical carcinoma. A clinical case report].
A rare case of primary hyperaldosteronism due to corticosuprarenal carcinoma is presented. The case was treated by suprarenalectomy and is currently under antiblastic treatment with mitotane (o-p'DDD). The clinical and endocrinological elements for differential diagnosis from the much more common suprarenal adenomas are examined in particular detail.
D000302:Adrenal Cortex / Q000473:pathology; D000306:Adrenal Cortex Neoplasms / Q000150:complications* / Q000473:pathology / Q000628:therapy; D000328:Adult; D002277:Carcinoma / Q000150:complications* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D003348:Cortisone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D008939:Mitotane / Q000627:therapeutic use
D008939:Mitotane; D003348:Cortisone
Iperaldosteronismo primario da carcinoma corticosurrenalico. Descrizione di un caso clinico.